APA

Hainsworth J. D., Murphy P. B., Alemar J. R., Daniel B. R., Young R. R. & Yardley D. A. (20171207). Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy. : Breast cancer research and treatment.

Chicago

Hainsworth John D, Murphy Patrick B, Alemar Jose R, Daniel Brooke R, Young Robyn R and Yardley Denise A. 20171207. Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy. : Breast cancer research and treatment.

Harvard

Hainsworth J. D., Murphy P. B., Alemar J. R., Daniel B. R., Young R. R. and Yardley D. A. (20171207). Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy. : Breast cancer research and treatment.

MLA

Hainsworth John D, Murphy Patrick B, Alemar Jose R, Daniel Brooke R, Young Robyn R and Yardley Denise A. Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy. : Breast cancer research and treatment. 20171207.